Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lipid nanoparticle drug delivery tech
Biotech
Oncology biotech licenses Genevant tech for up to $123M
The goal of the deal is to develop new mRNA-lipid nanoparticle therapies for an undisclosed cancer indication.
Darren Incorvaia
Dec 20, 2024 6:00am
2 biotechs shed staff, fuse to form genetic medicine company
Dec 11, 2024 7:00am
mRNA therapy reduced post-surgery eye scarring in rabbits
Nov 27, 2024 2:00pm
Carisma's Moderna-powered cell therapy shrinks tumors in mice
Nov 8, 2024 7:30am
Poseida gene therapy reduces kallikrein protein levels in mice
Oct 24, 2024 1:20pm
Editas prioritizes in vivo therapies, seeks reni-cel partner
Oct 22, 2024 9:39am
